Fujifilm Diosynth teamed with COVID-19 Therapeutics Accelerator to reserve manufacturing capacity for COVID-19 therapies

, , ,

On Apr. 30, 2020, FUJIFILM announced that it will reserve manufacturing capacity for a future COVID-19 therapy for the COVID-19 Therapeutics Accelerator. The Therapeutics Accelerator is an initiative launched by the Bill & Melinda Gates Foundation, Wellcome, and Mastercard to speed-up the response to the global pandemic.

Tags:


Source: FUJIFILM
Credit:

Advertise in our E-history sent to 5,000 plus company decision makers twice per month for only $300 per month. Reserve your space now! E-mail: info@LifeScienceHistory.com.